Remove Government Remove Healthcare Remove Pharmaceutical research Remove Safety
article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is worth mentioning that the government is the largest pharmaceutical buyer in Malaysia, responsible for more than half of the pharmaceutical purchasing value.

article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. According to GlobalData, global AI revenues in the pharmaceutical, medical, and healthcare sectors are expected to reach almost $21 billion by 2025. China takes an aim at recommendation algorithms.

Pharma 140
article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety.

Pharma 98